Skip to content
Screener

Ultralife ULBI Q1 2025 Annual earnings

Reported May 9, 2025 · Before market open

Revenue$50.7MMiss by $3.8M
EPS$0.13Miss by $0.02
Revenue estimate$54.5M
EPS estimate$0.15

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$56.0M
EPS estimate$0.23

Financials

Q1 2025

Income statement

See full
Revenue$50.7M+21.0%
Gross profit$11.5M+8.8%
Operating income-$1.5M-159%
Net income-$1.5M-193%
EPS (diluted)-$8.75-192%

Balance sheet

See full
Cash & equivalents$8.7M-13.7%
Total debt$57.5M+129%
Total equity$136.4M+5.9%
Total assets$223.8M+23.9%

Cash flow

See full
Operating cash flow$3.4M+4,258%
CapEx$895.0K+141%
Free cash flow$2.5M+646%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$89.45M-38.9%
Enterprise value$138.24M-14.4%
P/E27.4×+6.5×
P/S0.5×-0.4×

Profitability

See full
Gross margin25%+1.3pp
Operating margin3.5%-2.2pp
Net margin1.9%-2.3pp
FCF margin10.2%+9.1pp

Returns & leverage

See full
Return on equity2.5%-3.2pp
Debt / equity0.4×+0.2×
Current ratio3.2×-0.8×

Segments

By segment

See full
Battery Energy Products$46.3M+32.4%
Communications Systems$4.4M-36.2%

By geography

See full
US$39.5M—

FAQ

When did Ultralife report Q1 2025 earnings?
Ultralife (ULBI) reported Q1 2025 earnings on May 9, 2025 before market open.
What were Ultralife's Q1 2025 revenue and EPS?
Ultralife reported revenue of $50.7M and eps of $0.13 for Q1 2025.
Did Ultralife beat estimates in Q1 2025?
Revenue missed the consensus estimate of $54.5M by $3.8M. EPS missed the consensus estimate of $0.15 by $0.02.
How did Ultralife's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 21.0% from $41.9M a year earlier and eps declined 38.1% from $0.21.
Where can I find Ultralife's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001437749-25-015629) and the 10-K periodic report (0001437749-25-010360) directly on SEC EDGAR. The filing index links above go to sec.gov.